Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

NCT ID: NCT03624608

Last Updated: 2025-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-01

Study Completion Date

2025-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the efficacy of the AuryzoN devices in the ear and nose reconstruction surgeries, both in terms of operative time and overall quality of reconstruction. Research participants will undergo reconstruction either using the AuryzoN device or through current methods (traditional manual processing) at the discretion of their surgeon prior to the start of surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The AuryzoN devices are a family of two (2) devices that, in conjunction, serve to process substrates of autologous-derived or cadaveric cartilage used in the reconstruction of various structures of the body, namely ear and nose. The devices are to be used in the operating room to cut and carve substrates of tissue into components, which are then assembled into the final ear or nose, that will then be implanted by the plastic surgeon into the appropriate area. This device family serves to replace the current step in this reconstructive procedure, which involves the time-consuming and error-prone process of manual cartilage processing.

Participants will be given the option to participate in the study. If the participants so choose, they will undergo ear or nose reconstruction using the AuryzoN devices or traditional manual processing at the discretion of their surgeon prior to the start of surgery. The following outcome measures will be measured: operative time, error rates, objective quality outcomes of reconstruction, subjective quality outcomes of reconstruction, and patient satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ear Deformities, Acquired Ear; Deformity, Congenital Microtia Nose Deformity Nose Deformities, Acquired Nose; Deformity, Congenital Nose; Deformity, Congenital, Bent or Squashed Nose; Deformity, Syphilitic, Congenital Nose; Deformity, Bone (Nose Cartilage) Nose; Deformity, Septum, Congenital Nose; Deformity, Sinus (Wall), Congenital Nose; Deformity, Syphilitic, Late (Etiology) Ear; Deformity, External Ear; Deformity, Auricle, Ear, Acquired Ear; Deformity, Auricle, Ear (Congenital)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Auryzon-Processed Ear/Nose

Patients in this category underwent reconstruction and implantation of a completed ear/nose cartilaginous graft that was processed using the AuryzoN device.

Group Type EXPERIMENTAL

AuryzoN Family of Devices

Intervention Type DEVICE

The AuryzoN family of devices includes a longitudinal cartilage trimmer (DimensioN) and 2D shape carving machine with custom blades (AuryzoN).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AuryzoN Family of Devices

The AuryzoN family of devices includes a longitudinal cartilage trimmer (DimensioN) and 2D shape carving machine with custom blades (AuryzoN).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 1-100 of sufficient health required to undergo ear/nose reconstruction under general anesthesia
* Pre-existing physical deformity of the ear, nose, or eyelid necessitating surgical reconstruction
* Sufficient autologous or cadaveric rib cartilage for use by the AuryzoN system for cartilage processing

Exclusion Criteria

* Patients with ear/nose/eyelid deformities not requiring surgical correction
* Patients without sufficient rib cartilage for use by the AuryzoN system and those who do not desire cadaveric cartilage use
* Patients in poor health to undergo surgery under general anesthesia
* Patients whose desired ear/nose/eyelid exceeds the dimensions/shapes of those pre-fabricated blades used in the AuryzoN system
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Medical Center, Cincinnati

OTHER

Sponsor Role collaborator

Reconstrata, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angelo Leto Barone

Role: PRINCIPAL_INVESTIGATOR

Reconstrata, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cincinnati Children's Hospital

Cincinnati, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Leto Barone AA, Arun A, Samaha GJ, Shallal CC, Redett RJ, Steinberg JP. Design of a Novel Reproducible Cartilage-Sparing Autologous Technique for Microtia Repair. Facial Plast Surg Aesthet Med. 2021 May-Jun;23(3):224-229. doi: 10.1089/fpsam.2020.0457. Epub 2020 Nov 12.

Reference Type DERIVED
PMID: 33185490 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AZN-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robotic Surgery of the Ocular Surface
NCT02116062 TERMINATED NA
Cornea Preservation Time Study
NCT01537393 COMPLETED PHASE4